sur The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard's Position in Spire Healthcare Group Disclosed
The Vanguard Group, Inc. has submitted a Form 8.3 disclosure under the Takeover Code concerning its interests in Spire Healthcare Group plc. The disclosure was made on March 5, 2026, detailing Vanguard's position as holding 14,495,778 ordinary shares, representing a 3.6% stake in Spire Healthcare.
The filing also reported a recent purchase of 5,800 ordinary shares at a price of 1.95 GBP per unit. This activity reflects Vanguard's ongoing interest in maintaining a significant shareholding in the healthcare provider, although no cash-settled or stock-settled derivatives were noted in the disclosure.
No agreements, arrangements, or indemnity options encouraging further dealings were reported. The contact for this disclosure is Shawn Acker, reachable at 001-610-669-6713.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.